Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 44:1966-1969, doi:10.1016/j.jacc.2004.08.049
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, A.
Right arrow Articles by Scheinert, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, A.
Right arrow Articles by Scheinert, D.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Effect of two different neuroprotection systems on microembolization during carotid artery stenting

Andrej Schmidt, MD*, Klaus-Werner Diederich, MD, Susanne Scheinert, MD, Sven Bräunlich, MD, Tatjana Olenburger, Giancarlo Biamino, MD, Gerhard Schuler, MD and Dierk Scheinert, MD

Divisionof Clinical and Interventional Angiology, Department of Cardiology, University of Leipzig–Heart Center, Leipzig, Germany

Manuscript received April 30, 2004; accepted August 16, 2004.

* Reprint requests and correspondence: Dr. Andrej Schmidt, Clinical and Interventional Angiology, Department of Cardiology, University of Leipzig-Heart Center, Strümpellstrasse 39, 04289 Leipzig, Germany (Email: Andrej.Schmidt{at}gmx.de).

OBJECTIVES: This study sought to compare the efficacy of two different cerebral protection systems for the prevention of embolization during carotid artery stenting (CAS) using a transcranial Doppler (TCD) monitoring with the detection of microembolic signals (MES).

BACKGROUND: Despite the introduction of cerebral protection systems, neurologic complications during CAS cannot completely be prevented. Transcranial Doppler and detection of MES may aid in assessing the efficacy of different neuroprotection systems.

METHODS: A total of 42 patients with internal carotid artery stenoses were treated by CAS using either a filter (E.P.I. FilterWire, Boston Scientific Corp., Santa Clara, California) (n = 21) or a proximal endovascular clamping device (MO.MA system, Invatec s.r.l., Roncadelle, Italy) (n = 21). Microembolic signal counts were compared during five phases: placement of the protection device, passage of the stenosis, stent deployment, balloon dilation, and retrieval of the protection device.

RESULTS: There were no significant differences in clinical or angiographic outcomes between the two groups. Compared to the filter device, the MO.MA system significantly reduced MES counts during the procedural phases of wire passage of the stenosis, stent deployment, balloon dilation, and in total (MES counts for the filter device were 25 ± 22, 73 ± 49, 70 ± 31, and 196 ± 84 during the three phases and in total, MES counts for the MO.MA system were 1.8 ± 3.2, 11 ± 19, 12 ± 21, and 57 ± 41, respectively; p < 0.0001).

CONCLUSIONS: In comparison to a filter device the MO.MA system led to significantly lower MES counts during CAS. The detection of MES by TCD may facilitate the evaluation and comparison of different neuroprotection systems.

Abbreviations and Acronyms
  CAS = carotid artery stenting
  CCA = common carotid artery
  ECA = external carotid artery
  ICA = internal carotid artery
  MES = microembolic signals
  TCD = transcranial Doppler




This article has been cited by other articles:


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
R. K. Veeraswamy, B. G. Rubin, L. A. Sanchez, M. A. Curi, P. J Geraghty, J. C. Parodi, and G. A. Sicard
Complications of Carotid Artery Stenting Are Largely Preventable: A Retrospective Error Analysis
Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2007; 19(4): 403 - 408.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
K. Shilling, B. F. Uretsky, and G. C. Hunter
Entrapment of a Cerebral Embolic Protection Device: A Case Report
Vascular and Endovascular Surgery, May 1, 2006; 40(3): 229 - 233.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
F. Asakura, K. Kawaguchi, H. Sakaida, N. Toma, S. Matsushima, K. Kuraishi, H. Tanemura, Y. Miura, M. Maeda, and W. Taki
Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 753 - 758.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
J. C. Lin, R. R. Kolvenbach, and L. Pinter
Protected Carotid Artery Stenting and Angioplasty via Transfemoral versus Transcervical Approaches
Vascular and Endovascular Surgery, November 1, 2005; 39(6): 499 - 503.
[Abstract] [PDF]


Home page
Vasc MedHome page
Y. P. Liew and J. R Bartholomew
Atheromatous embolization
Vascular Medicine, November 1, 2005; 10(4): 309 - 326.
[Abstract] [PDF]


Home page
StrokeHome page
H. D. Aronow, M. Shishehbor, D. A. Davis, I. L. Katzan, D. L. Bhatt, C. T. Bajzer, A. Abou-Chebl, K. W. Derk, P. L. Whitlow, and J. S. Yadav
Leukocyte Count Predicts Microembolic Doppler Signals During Carotid Stenting: A Link Between Inflammation and Embolization
Stroke, September 1, 2005; 36(9): 1910 - 1914.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Parodi
Effect of Two Different Neuroprotection Systems on Microembolization During Carotid Artery Stenting
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 382 - 382.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Schmidt, D. Scheinert, and G. Biamino
Reply
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 382 - 382.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement